Roivant Sciences Ltd. (ROIV)

32.41 +4.20 (+14.89%) USD  |  NASDAQ  |  May 20, 16:00
32.33 -0.08 (-0.25%) After-Hours: 16:18
More

Roivant Sciences EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ROIV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Arbutus Biopharma Corp. Upgrade
Moderna, Inc. Upgrade
Centessa Pharmaceuticals Plc Upgrade
Silence Therapeutics Plc Upgrade
Adaptimmune Therapeutics Plc --